The combination of Etamsylate and Tranexamic acid belongs to hemostatic agents. It is used to control excessive bleeding in conditions like heavy menstrual bleeding and post-surgical bleeding.

The combination of Etamsylate and Tranexamic acid is used to manage excessive bleeding in various conditions. Etamsylate enhances platelet aggregation to promote blood clotting, while Tranexamic acid prevents the breakdown of clots by inhibiting fibrinolysis. Doctors commonly prescribe this combination to treat heavy menstrual bleeding (menorrhagia), control bleeding during and after surgeries (such as dental, orthopaedic, or gynaecological procedures), and manage bleeding in trauma or post-childbirth situations. It is also effective in preventing and treating bleeding episodes in conditions like nosebleeds or gastrointestinal bleeding.

The combination of Etamsylate and Tranexamic acid can be administered either orally or intravenously. For oral use, it is important to follow the instructions regarding whether to take it before or after food. The tablets should not be broken, chewed, or crushed. When administered intravenously, it is done under the supervision of a healthcare provider. It is essential to consult a healthcare provider for the correct dosage and administration based on individual needs.

Side effects are unwanted symptoms caused by medicines. Although all drugs can cause side effects, not everyone experiences them.

Common side effects of Etamsylate and Tranexamic acid are:

• Nausea and vomiting
• Diarrhea
• Dizziness and headache
• Fatigue

Serious side effects of Etamsylate and Tranexamic acid are:

• Blood clot formation (deep vein thrombosis, pulmonary embolism)
• Severe allergic reactions such as rash, itching, swelling, difficulty breathing
• Vision disturbances
• Chest pain or discomfort
• Severe abdominal pain
• Shortness of breath

• Blood clot risk: The combination can increase the risk of blood clots, especially in individuals with a history of clotting disorders, deep vein thrombosis, or pulmonary embolism.
• Kidney issues: Patients with kidney impairment should use the combination with caution, as it may affect renal function.
• Allergic reactions: Monitor for signs of severe allergic reactions, such as rash, itching, swelling, or difficulty breathing.
• Pregnancy and breast-feeding: Consult a healthcare provider before using the combination during pregnancy or breastfeeding.
• Pre-existing medical conditions: Patients with a history of thromboembolic events or active bleeding disorders should use the combination with caution.
• Drug interactions: The combination may interact with medications affecting blood clotting, such as anticoagulants.

If you have a history of blood clotting disorders, kidney issues, or active bleeding conditions, take precautions when using the combination of Etamsylate and Tranexamic acid. Consult a healthcare provider before using it if you are pregnant or breastfeeding. Monitor for allergic reactions and inform your doctor about any other medications you are taking, especially anticoagulants, to prevent potential interactions. Always follow your healthcare provider’s guidance on dosage and use.

Consult your healthcare provider before using the combination of Etamsylate and Tranexamic acid if you have a history of blood clotting disorders, kidney issues, or active bleeding conditions. Avoid using this combination during pregnancy or breastfeeding without medical advice. Monitor for any allergic reactions and report unusual symptoms to your doctor. Inform your doctor about any other medications you are taking, especially anticoagulants, to prevent potential interactions.

1. Garay RP, Chiavaroli C, Hannaert P. Therapeutic efficacy and mechanism of action of ethamsylate, a long-standing hemostatic agent. https://pubmed.ncbi.nlm.nih.gov/16772766/

2. Schulte J, Osborne J, Benson JW, Cooke R, Drayton M, Murphy J, Rennie J, Speidel B. Developmental outcome of the use of etamsylate for prevention of periventricular haemorrhage in a randomised controlled trial. https://pubmed.ncbi.nlm.nih.gov/15613570/

3. Cai J, Ribkoff J, Olson S, Raghunathan V, Al-Samkari H, DeLoughery TG, Shatzel JJ. The many roles of tranexamic acid: An overview of the clinical indications for TXA in medical and surgical patients. Eur J Haematol. https://pmc.ncbi.nlm.nih.gov/articles/PMC7023891/

4. Trauma and severe bleeding. Tranexamic acid within one hour to reduce mortality. https://pubmed.ncbi.nlm.nih.gov/23951599/

The drug information on this page is not a substitute for medical advice. It is meant for educational purposes only. For further details, consult your doctor about your medical condition to know if you can receive this treatment.